Guo Lingxi, Wu Xiaojing, Cui Xiaoyang, Li Meiyuan, Yang Lu, Feng Yiming, Zhan Qingyuan, Huang Linna
National Center for Respiratory Medicine, Beijing, PR China.
State Key Laboratory of Respiratory Health and Multimorbidity, Beijing, PR China.
Kidney Dis (Basel). 2024 May 7;10(4):262-273. doi: 10.1159/000539139. eCollection 2024 Aug.
The incidence and impact of acute kidney injury (AKI) in patients with invasive pulmonary aspergillosis (IPA) admitted to the intensive care unit (ICU) are unknown.
This retrospective study included 140 patients who were diagnosed with IPA and admitted to the medical ICU of China-Japan Friendship Hospital in Beijing, China. AKI was defined according to the Kidney Disease: Improving Global Outcomes guidelines. Data on demographic characteristics, comorbidities, laboratory tests, treatments, and prognosis at ICU admission were collected.
The rate of AKI was 71.4% ( = 100), and approximately 30% of the patients had preadmission acute kidney dysfunction. Of the 100 patients with AKI, 19, 8, and 73 patients had stage I, II, and III AKI, respectively, and 64 (87.6%) patients required continuous renal replacement therapy. Overall ICU mortality rate was 52.1%. Irreversible AKI was a strong independent risk factor for ICU mortality (odds ratio 13.36, 95% confidence interval 4.52-39.48, < 0.001), followed by chronic lung disease, use of intermittent positive-pressure ventilation, and long-term corticosteroid treatment within 1 year prior to ICU admission. Higher cardiac troponin I levels at admission and worse volume control during the first 7 days of ICU stay were potential predictive factors of irreversible kidney dysfunction. Patients with irreversible AKI and those who died during the ICU stay had greater volume overload during the first 14 days of ICU stay. Patients who survived received earlier renal replacement therapy support after ICU admission compared to those who died (median, 2 vs. 5 days; = 0.026).
Compared to the patients with IPA in the absence of AKI, those with AKI presented with more volume overload, worse disease burden, and required stronger respiratory support, while experiencing worse prognosis. Irreversible AKI was a strong predictor of mortality in patients with critical IPA. Better volume control and earlier CRRT initiation should be considered key points in AKI management and prognostic improvement.
入住重症监护病房(ICU)的侵袭性肺曲霉病(IPA)患者中急性肾损伤(AKI)的发生率及影响尚不清楚。
这项回顾性研究纳入了140例被诊断为IPA并入住中国北京中日友好医院内科ICU的患者。AKI根据改善全球肾脏病预后组织(KDIGO)指南进行定义。收集了患者入住ICU时的人口统计学特征、合并症、实验室检查、治疗及预后等数据。
AKI发生率为71.4%(n = 100),约30%的患者入院前存在急性肾功能不全。在100例AKI患者中,分别有19例、8例和73例为Ⅰ期、Ⅱ期和Ⅲ期AKI,64例(87.6%)患者需要连续性肾脏替代治疗(CRRT)。ICU总体死亡率为52.1%。不可逆性AKI是ICU死亡的强有力独立危险因素(比值比13.36,95%置信区间4.52 - 39.48,P < 0.001),其次是慢性肺部疾病、使用间歇正压通气以及入住ICU前1年内长期使用糖皮质激素治疗。入院时心肌肌钙蛋白I水平较高以及入住ICU的前7天内容量控制较差是不可逆性肾功能不全的潜在预测因素。不可逆性AKI患者及在ICU住院期间死亡的患者在入住ICU的前14天内容量超负荷情况更严重。存活患者在入住ICU后比死亡患者更早接受肾脏替代治疗支持(中位数分别为2天和5天;P = 0.026)。
与无AKI的IPA患者相比,合并AKI的患者容量超负荷更严重、疾病负担更重、需要更强的呼吸支持,且预后更差。不可逆性AKI是重症IPA患者死亡的强有力预测因素。更好的容量控制和更早开始CRRT应被视为AKI管理及改善预后的关键点。